药物支架不良事件分析研究

来源 :上海食品药品监管情报研究 | 被引量 : 0次 | 上传用户:wangguoqiang123
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
近年来,经冠状动脉介入术(PCI)已经成为冠心病治疗的一个重要手段,其显著疗效亦被大规模的临床试验所证实。但球囊扩张术及传统金属裸支架植入术后,其中、短期内出现再狭窄的发生率达20-50%[1],严重限制了PCI的发展,其主要原因为血管壁弹性回缩、支架邻近血管重塑、炎症、血管内膜增生。 In recent years, percutaneous coronary intervention (PCI) has become an important means of treatment of coronary heart disease, and its significant effect has also been confirmed by large-scale clinical trials. However, balloon dilatation and conventional bare metal stent implantation, of which short-term restenosis occurs in the rate of 20-50% [1], severely limited the development of PCI, the main reason for the elastic retraction of the vessel wall , Stents adjacent to vascular remodeling, inflammation, intimal hyperplasia.
其他文献